Cronos (CRON) Other Non-Current Assets (2020 - 2025)
Cronos (CRON) posted quarterly Other Non-Current Assets of $2.9 million for Q3 2025, up 2110.0% year-over-year from $130000.0 in Q3 2024, and up 2110.0% quarter-over-quarter from $130000.0 in Q3 2024.
Cronos (CRON) Other Non-Current Assets (2020 - 2025) Analysis & Trends
Cronos' Other Non-Current Assets history runs 6 years deep, the most recent figure standing at $2.9 million for Q3 2025.
- In Q3 2025, Other Non-Current Assets rose 2110.0% year-over-year to $2.9 million; the TTM figure through Sep 2025 stood at $2.9 million (up 2110.0% YoY), while the FY2023 annual figure was $45000.0, down 76.68% from the prior year.
- Other Non-Current Assets for Q3 2025 stood at $2.9 million, up from $130000.0 in the prior quarter.
- The five-year high for Other Non-Current Assets was $19.4 million in Q1 2024, with the low at $41000.0 in Q2 2024.
- The 5-year median for Other Non-Current Assets is $149000.0 (2022), against an average of $2.1 million.
- The sharpest annual moves came in 2021 and 2025: Other Non-Current Assets sank 78.59% in 2021, then jumped 2110.0% in 2025.
- Cronos' Other Non-Current Assets stood at $100000.0 in 2021, then soared by 93.0% to $193000.0 in 2022, then tumbled by 76.68% to $45000.0 in 2023, then surged by 188.89% to $130000.0 in 2024, then surged by 2110.0% to $2.9 million in 2025.
- Business Quant data shows CRON's Other Non-Current Assets at $2.9 million in Q3 2025, $130000.0 in Q3 2024, and $41000.0 in Q2 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | 56.35 Mn |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | 1.79 Bn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | 384.00 Mn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 503.80 Mn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | 239.50 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | 1.06 Bn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | 59.30 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | 304.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | 13.00 Mn |
| 10 | Cronos | 1.23 Bn | 437.76 Mn | 28.45 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 2.87 Mn |
| Sep 30, 2024 | 130,000.00 |
| Jun 30, 2024 | 41,000.00 |
| Mar 31, 2024 | 19.40 Mn |
| Dec 31, 2023 | 45,000.00 |
| Mar 31, 2023 | 1.48 Mn |
| Dec 31, 2022 | 193,000.00 |
| Sep 30, 2022 | 168,000.00 |
| Jun 30, 2022 | 89,000.00 |
| Mar 31, 2022 | 70,000.00 |
| Dec 31, 2021 | 100,000.00 |
| Sep 30, 2021 | 780,000.00 |
| Dec 31, 2020 | 467,000.00 |